Research analysts at StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) in a research note issued to investors on Friday. The firm set a “sell” rating on the stock.
Ampio Pharmaceuticals Price Performance
AMPE stock opened at $0.00 on Friday. The company has a market cap of $681.00, a P/E ratio of 0.00 and a beta of 3.66. Ampio Pharmaceuticals has a twelve month low of $0.00 and a twelve month high of $2.47. The business’s fifty day moving average is $0.01 and its 200-day moving average is $0.01.
Ampio Pharmaceuticals Company Profile
Further Reading
- Five stocks we like better than Ampio Pharmaceuticals
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Investing in Small-Cap AI: Powering the Next Tech Revolution
- Why is the Ex-Dividend Date Significant to Investors?
- Occidental Petroleum Drops to 52-Week Low: Buy, Sell, or Hold?
- Using the MarketBeat Dividend Yield Calculator
- Super Micro Computer Is Now NASDAQ Compliant—But Is It a Buy?
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
